Shree Pacetronix Ltd (SHREEPAC)

Loading page…

Shree Pacetronix Ltd (SHREEPAC) · mywealthgrid

About

Shree Pacetronix Ltd operates in Medical Equipment & Supplies within the Healthcare sector.

Face value: ₹10

Market cap

₹68 Cr

P/E

374.0×

P/B

3.8×

Dividend yield

ROE

18.9%

ROCE

27.4%

Debt / equity

0.14

OPM

23.5%

EPS (TTM)

₹0.5

Book value

₹48.3

52-week high

—

52-week low

—

1,328 historical price candles were omitted because the exchange source has not been verified.

₹185.0-1.6%1Y

Quick read

rule-based

Pros

+High return on capital employed of 26.9%
+Healthy operating margin of 23.5%
+Profit CAGR of 75.8% over the last 5 years
+Revenue CAGR of 23.4% over the last 5 years
+Comfortable interest coverage of 11.5×

Cons

−Expensive at 374× trailing earnings

Research score

Structured signal from quality, growth, valuation and momentum.

31/100

Business quality: 72
Growth: 2
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	7	7	7	7	9	8	9	20	22	17	22
COGS	-3	-3	-3	-3	-3	3	3	7	7	6	6
Gross profit	—	—	—	—	—	5	6	13	15	11	15
	10	9	9	10	11	4	4	8	9	9	10
	0	0	1	1	1	1	2	5	6	2	5
OPM %	5.5%	0.9%	12.3%	10.3%	14%	14.7%	17.7%	26.9%	25.7%	13.1%	23.5%
Depreciation	—	—	0	0	1	1	1	1	1	1	1
Interest	0	0	0	0	0	0	0	0	0	1	0
	—	0	0	0	0	0	0	0	0	0	0
Profit before tax	0	-0	0	0	0	0	1	5	5	1	4
Tax	0	-0	0	0	0	0	0	1	1	0	1
Tax %	114.3%	-27.5%	45.5%	41.7%	34.2%	41.9%	26.1%	29.4%	27.3%	27.9%	26.2%
	0	-0	0	0	0	0	1	3	3	1	3
PAT margin %	0%	-4.2%	1.2%	1.9%	3.2%	2.4%	7.2%	16.1%	15.3%	4.5%	14%
EPS (₹)	-0	-0.8	0.3	0.4	0.8	0.5	1.8	9	—	—	8.3
EPS adjusted (₹)	—	—	—	—	—	0.5	1.8	9	9.3	2.1	8.1
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	4	4	4	4	4	4
Reserves	2	3	6	10	10	14
	3	3	2	4	5	3
	2	3	5	4	4	5
Total equity & liabilities	11	12	17	22	23	26
	3	3	3	4	3	4
CWIP	—	0	0	—	—	1
Investments	1	1	1	1	1	1
	7	9	13	17	19	21
Total assets	11	12	17	22	23	26

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	65.2%	65.4%	65.8%	66.7%	67%	70.4%
EBITDA margin %	10.3%	14%	14.7%	17.7%	26.9%	25.7%	13.1%	23.5%
EBIT margin %	5.1%	8.2%	7.9%	12.2%	23.8%	22%	8.9%	20.1%
PAT margin %	1.9%	3.2%	2.4%	7.2%	16.1%	15.3%	4.5%	14%
Working capital
Receivable days	—	—	195	210	109	96	165	179
Inventory days	—	—	272	194	157	286	463	275
Payable days	—	—	47	18	32	12	57	70
NWC days	—	—	419	386	234	370	571	385
Leverage
Current ratio	—	—	1.64	1.67	1.87	1.99	2.07	2.69
Debt to EBITDA	—	—	2.47	1.79	0.4	0.75	2.26	0.51
Debt to equity	—	—	0.46	0.44	0.22	0.32	0.36	0.14
Interest coverage	1.8	2.1	1.9	4.1	16.3	13.9	2.8	11.5
Asset turnover	—	—	0.71	0.75	1.22	1.01	0.73	0.84
Return ratios
Return on assets %	—	—	1.7%	5.4%	19.6%	15.4%	3.3%	11.7%
Return on capital employed %	—	—	10.1%	17.1%	56.6%	41.8%	11.6%	27.4%
Return on equity %	—	—	3.1%	9.9%	33.2%	25.5%	5.4%	16.7%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	24.25%	24.25%	24.25%	24.25%	24.25%	24.25%	24.25%	24.25%	24.25%	25.8%	31.7%	36.44%
	0%	0%	0%	0%	0%	0%	0%	0%	0.14%	0.14%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	75.75%	75.75%	75.75%	75.75%	75.75%	75.75%	75.75%	75.75%	75.61%	74.06%	68.3%	63.56%
No. of shareholders	—	—	—	—	—	—	—	—	6,665	6,529	6,567	6,615

Promoter holding up 12.19 percentage points since Sep 2023.

34 deals · 19 May 2023 – 29 Jun 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
29 Jun 2026	TASNEEM KHAMBATY	Bulk	BSE	Sell	20,250	₹124.69	₹0.25 Cr
29 Jun 2026	PRATYUSH MITTAL	Bulk	BSE	Buy	18,773	₹125.54	₹0.24 Cr
8 Jan 2026	SANJAY PHULCHAND KULAR	Bulk	BSE	Sell	19,000	₹165.91	₹0.32 Cr
5 Jan 2026	AMIT KUMAR	Bulk	BSE	Sell	20,653	₹156.71	₹0.32 Cr
30 Dec 2025	DHEERAJ KUMAR LOHIA	Bulk	BSE	Buy	24,000	₹182.90	₹0.44 Cr
30 Dec 2025	SANJAY PHULCHAND KULAR	Bulk	BSE	Sell	23,805	₹182.90	₹0.44 Cr
29 Dec 2025	SANJAY PHULCHAND KULAR	Bulk	BSE	Sell	20,647	₹192.57	₹0.40 Cr
22 Dec 2025	ABHISHEK SINGHVI	Bulk	BSE	Sell	25,510	₹203.74	₹0.52 Cr
12 Dec 2025	SANJAY PHULCHAND KULAR	Bulk	BSE	Buy	45,920	₹265.20	₹1.22 Cr
12 Dec 2025	SANJAY PHULCHAND KULAR	Bulk	BSE	Sell	2,509	₹261.73	₹0.07 Cr

1–10 of 34

1 / 4

Mr. Atul Kumar SethiManaging Director
Sumit ChakarbartiChief Operating Officer
Mr. Akash SethiJoint Managing Director
Ashok AtulkarChief Financial Officer
Ms. Manali TongiaNon-Executive Independent Woman Director
Ms. Somya ChhabraNon-Executive Independent Woman Director
Mr. Chandragupt JainNon-Executive - Independent Director
Ms. Rupali AhireCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Shree Pacetronix Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Final dividend24 Sept 2007 · ex-date₹0.5

1

Board meeting to consider results13 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

106 announcementsExport CSV

13 Aug 2026, 5:17 pmCompany Update

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	65.2%	65.4%	65.8%	66.7%	67%	70.4%
EBITDA margin %	10.3%	14%	14.7%	17.7%	26.9%	25.7%	13.1%	23.5%
EBIT margin %	5.1%	8.2%	7.9%	12.2%	23.8%	22%	8.9%	20.1%
PAT margin %	1.9%	3.2%	2.4%	7.2%	16.1%	15.3%	4.5%	14%
Working capital
Receivable days	—	—	195	210	109	96	165	179
Inventory days	—	—	272	194	157	286	463	275
Payable days	—	—	47	18	32	12	57	70
NWC days	—	—	419	386	234	370	571	385
Leverage
Current ratio	—	—	1.64	1.67	1.87	1.99	2.07	2.69
Debt to EBITDA	—	—	2.47	1.79	0.4	0.75	2.26	0.51
Debt to equity	—	—	0.46	0.44	0.22	0.32	0.36	0.14
Interest coverage	1.8	2.1	1.9	4.1	16.3	13.9	2.8	11.5
Asset turnover	—	—	0.71	0.75	1.22	1.01	0.73	0.84
Return ratios
Return on assets %	—	—	1.7%	5.4%	19.6%	15.4%	3.3%	11.7%
Return on capital employed %	—	—	10.1%	17.1%	56.6%	41.8%	11.6%	27.4%
Return on equity %	—	—	3.1%	9.9%	33.2%	25.5%	5.4%	16.7%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Molbio Diagnostics LimitedMOLBIOMOLBIO	₹17,431 Cr	₹17,844 Cr	₹1,020 Cr	₹262 Cr	25.7%	₹145 Cr	13.6%	23.7%	16.2%	—
Poly Medicure LimitedPOLYMEDPOLYMED	₹16,610 Cr	₹16,952 Cr	₹1,997 Cr	₹461 Cr	23.6%	₹315 Cr	17.1%	14.5%	11%	294
Fischer Medical Ventures LimitedFISCHERFISCHER	₹2,190 Cr	₹2,262 Cr	₹367 Cr	₹50 Cr	14%	₹30 Cr	10.1%	13.6%	8.6%	111
Tarsons Products LimitedTARSONSTARSONS	₹1,752 Cr	₹2,135 Cr	₹441 Cr	₹119 Cr	27.9%	₹11 Cr	3.4%	5%	2.3%	361
Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL	₹1,066 Cr	₹1,066 Cr	₹287 Cr	₹46 Cr	15.6%	₹31 Cr	10.4%	14.7%	12.8%	109
Hemant Surgical Industries LtdHSILHSIL	₹885 Cr	—	₹232 Cr	₹23 Cr	10%	₹18 Cr	7.9%	—	—	—
Fabtech Technologies LimitedFABTECHFABTECH	₹632 Cr	₹675 Cr	₹418 Cr	₹45 Cr	8.5%	₹49 Cr	9.3%	15.5%	12.9%	55
Prevest Denpro LtdPREVESTPREVEST	₹452 Cr	—	₹72 Cr	₹25 Cr	34.4%	₹20 Cr	28.5%	—	—	—
Nureca LimitedNURECANURECA	₹332 Cr	₹333 Cr	₹153 Cr	₹4 Cr	0.1%	₹4 Cr	1.4%	3.3%	1.1%	186
Earkart LtdEARKARTEARKART	₹179 Cr	₹179 Cr	₹54 Cr	₹8 Cr	15.5%	₹5 Cr	9.1%	12.1%	7.7%	243
Choksi Asia LtdCHOKSICHOKSI	₹117 Cr	₹119 Cr	₹11 Cr	₹-2 Cr	13.8%	₹2 Cr	10.8%	18.9%	13.5%	142
Shree Pacetronix LtdSHREEPACSHREEPAC	₹68 Cr	₹71 Cr	₹8 Cr	₹1 Cr	23.5%	₹0 Cr	14%	27.4%	18.9%	385

Date	Category	Subject	Filing
13 Aug 2026, 5:17 pm	Company Update General	Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015	PDF
11 Aug 2026, 4:49 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
10 Jul 2026, 3:37 pm	Company Update Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	PDF
26 Jun 2026, 5:05 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
10 Jun 2026, 5:46 pm	Company Update General	Disclosure Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 ('SEBI (SAST) Regulations')	PDF
10 Jun 2026, 5:37 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
10 Jun 2026, 5:21 pm	Insider Trading / SAST Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011	PDF
5 Jun 2026, 6:10 pm	Company Update General	Intimation To The Holders Of Physical Shares In Terms Of SEBI Circular No. SEBI/HO/38/13/ (4)2026-MIRSD-POD/I/4298/2026 Dated February 6, 2026 Regarding Mandatory Furnishing Of PAN, KYC Details And Nomination.	PDF

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1	1	2	-0	0	4
	-1	-1	-1	-2	-0	-2
	-0	-0	-1	2	0	-1
Net cash flow	0	-1	0	0	0	1
Free cash flow	0	0	1	-1	-1	4
CFO / Operating profit %	89.2%	36.9%	45%	-0.5%	2.3%	76%

Shree Pacetronix Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

1

1

Announcements

1

1

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Compounded sales growth

Compounded profit growth

Return on equity

Shree Pacetronix Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Dividends1

Board meetings1

Announcements

Dividends1

Board meetings1

Ratio timeline

Not in the F&O segment

No fund holdings on record

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

1

1

1